Does ENFORTUMAB VEDOTIN Cause Therapy partial responder? 45 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Therapy partial responder have been filed in association with ENFORTUMAB VEDOTIN (PADCEV EJFV). This represents 3.2% of all adverse event reports for ENFORTUMAB VEDOTIN.
45
Reports of Therapy partial responder with ENFORTUMAB VEDOTIN
3.2%
of all ENFORTUMAB VEDOTIN reports
12
Deaths
13
Hospitalizations
How Dangerous Is Therapy partial responder From ENFORTUMAB VEDOTIN?
Of the 45 reports, 12 (26.7%) resulted in death, 13 (28.9%) required hospitalization, and 3 (6.7%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does ENFORTUMAB VEDOTIN Cause?
Rash (173)
Neuropathy peripheral (172)
Malignant neoplasm progression (166)
Decreased appetite (106)
Diarrhoea (96)
Pruritus (83)
Alopecia (78)
Inappropriate schedule of product administration (73)
Pyrexia (70)
Hyperglycaemia (69)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which ENFORTUMAB VEDOTIN Alternatives Have Lower Therapy partial responder Risk?
ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN vs ENFUVIRTIDE
ENFORTUMAB VEDOTIN vs ENOXAPARIN
ENFORTUMAB VEDOTIN vs ENOXAPARIN - WINTHROP